Britain approves Merck's COVID-19 pill
The green light is the first for an oral treatment for COVID-19 and the first for a COVID-19 drug that will be administered widely in the community.
An experimental COVID-19 treatment pill called molnupiravir being developed by Merck & Co Inc and Ridgeback Biotherapeutics LP, is seen in this undated handout photo released by Merck & Co Inc and obtained by Reuters May 17, 2021.(photo credit: MERCK & CO INC/HANDOUT VIA REUTERS)
